Table 1 Demographic and clinical characteristics of the study cohort.
From: Breath biomarkers of insulin resistance in pre-diabetic Hispanic adolescents with obesity
Borderline (N = 7±) HOMA-IR 2.60–3.80 | Insulin resistance (N = 15) HOMA-IR > 3.80 | Normal (N = 6) HOMA-IR < 2.60 | Total (N = 28) | p value# | |
|---|---|---|---|---|---|
BMI (% of the 95th Percentile) | < 0.001 | ||||
131.14 (12.33) | 145.20 (21.69) | 127.83 (16.57) | 137.96 (20.15) | ||
Cholesterol | 0.951 | ||||
162.00 (20.74) | 160.66 (28.40) | 159.16 (48.11) | 160.67 (31.84) | ||
LDL | 0.137 | ||||
114.14 (22.38) | 107.333 (23.177) | 99.83 (33.59) | 107.42 (25.79) | ||
HDL | < 0.001 | ||||
36.614 (5.287) | 43.82 (6.05) | 49.81 (20.25) | 43.30 (11.48) | ||
Triglycerides | 0.13 | ||||
107.42 (34.26) | 115.26 (79.19) | 85.00 (21.10) | 106.82 (62.07) | ||
Glucose (mg/dL) | < 0.001 | ||||
86.28 (7.27) | 96.73 (16.44) | 83.66 (5.58) | 91.32 (14.07) | ||
Insulin mU/L | < 0.001 | ||||
14.87 (1.56) | 29.32 (12.72) | 10.56 (1.84) | 21.68 (12.54) | ||
Glucose/insulin ratio | < 0.001 | ||||
0.32 (0.05) | 0.20 (0.05) | 0.45 (0.10) | 0.28 (0.12) | ||
¥HOMA-IR | < 0.001 | ||||
3.16 (0.39) | 7.40 (5.16) | 2.16 (0.33) | 5.22 (4.46) | ||
≠FIRI | < 0.001 | ||||
0.23 (0.03) | 0.14 (0.03) | 0.32 (0.07) | 0.20 (0.08) | ||
A1C | 0.008 | ||||
5.00 (0.26) | 5.30 (0.59) | 5.06 (0.17) | 5.17 (0.47) | ||
AST | < 0.001 | ||||
20.00 (9.09) | 31.46 (17.38) | 21.00 (4.71) | 26.59 (14.80) | ||
ALT | < 0.001 | ||||
24.66 (16.27) | 50.40 (32.80) | 24.83 (9.94) | 39.00 (28.90) | ||
CRP | 0.068 | ||||
0.65 (0.69) | 0.78 (0.94) | 0.29 (0.30) | 0.65 (0.80) | ||
Sex | 0.559 | ||||
F | 2 (28.6%) | 6 (40.0%) | 2 (33.3%) | 10 (35.7%) | |
M | 5 (71.4%) | 9 (60.0%) | 4 (66.7%) | 18 (64.3%) |
